Applause to Editor of Amer J of Hypertension Who Said NO to financially compromised Society Fri, 29 Jul 2005 The Wall Street Journal reports: “In a dispute reflecting heightened concerns about the control and credibility of medical information, the American Society of Hypertension said it is severing its 16-year relationship…
TeenScreen: the Law Suits Begin Mon, 13 Jun 2005 Newsworthy developments about the duo-drug promotion scam‹TeenScreen & TMAP: A. The first legal challenge against TeenScreen, the mental health screening scheme that is invading the public school system across the nation, declaring otherwise normal children to be mentally ill, has been…
AMERICA’S OVERMEDICATED CHILDREN By Vera Sharav YOUTH and MEDICINES in June 1-3, 2005 KILEN: Consumers Institute for Medicines and Health SWEDEN “Forgotten Children” is an investigative report by Carole Keeton Strayhorn,[1] the Texas Comptroller (2004) who uncovered evidence that 60% of children in the Texas foster care system are being…
“Forgotten Children” is an investigative report by Carole Keeton Strayhorn,[1] the Texas Comptroller (2004) who uncovered evidence that 60% of children in the Texas foster care system are being drugged with powerful psychotropic drugs, most of which have not been tested in or approved for use by children. The Food and Drug Administration (FDA) acknowledges that many of these drugs have serious adverse side effects, both physical and psychological. The Comptroller said she was alarmed that in her review of a single month (November 2003), two powerful antipsychotic drugs — Risperdal and Zyprexa — made up half of the drugs prescribed to foster children in Texas. These two drugs have been approved only for adults for the treatment of psychosis – primarily schizophrenia – yet, she found that children as young as four, were receiving these powerful, mind-altering drugs.
What Ails the FDA? Payola – Marcia Angell Boston Globe Thu, 10 Mar 2005 The Boston Globe reports that the FDA is scrambling to put out one drug crisis after another, doing a poor job in both its areas of responsibility: medicine and food. FDA acting chief, Lester Crawford, cancelled…
NIH Scientists Gripe At Ethics Rule: NO Stocks in Pharmaceutical Companies – LAT / WSJ Sat, 5 Mar 2005 A group of dissident NIH scientists represented by an 18 member executive committee, are gripping about new rules prohibiting them from accepting fees for outside activities. Conflict of interest rules apply…
What’s a Patient to Think? Prescription for Confusion – NY Times Editorial Tue, 28 Dec 2004 At long last, The New York Times has validated the well-placed anger and frustration that patients feel at having their trust in medicine and the nation’s oversight agents betrayed: “Now I just don’t trust…
Free Academic Drug Tests – NYT Editorial Delivers Fatal Blow to Leaders of Psychiatry Tue, 30 Nov 2004 Today’s editorial in The New York Times is a follow-up to yesterday’s solid report by Barry Meier, that focused on the culpability of academic researchers and their prestigious medical institutions in undermining…
2/3 Institute of Medicine AIDS research panel have Conflicts of Interst – Assoc Press Thu, 17 Mar 2005 On Feb 25, the New York Times reported that 10 of 32 FDA panelists determining whether to recommend that COX 2 painkillers should allowed to be marketed despite the documented increased risk…
Efforts to promote Cymbalta for Fibromyalgia symptoms Wed, 20 Oct 2004 Cymbalta (duloxetine) was approved by the FDA as a treatment for depression in adults. No doubt in an effort to expand the drugs’ market, Eli Lilly tested the drug in patients with fibromyalgia. The published report claims women who…
Govt Prozac study Recommends MANDATORY Screening & Drugs – “Overdosed America”_OpEd NYT Sun, 19 Sep 2004 FDA’s Review of Safety & Efficacy Concerns in Anti-Depressant Use by Children is the subject of a second Congressional hearing by the House Energy & Commerce Subcommittee on Oversight / Investigations on September 23,…
18% decrease SSRI use in Youth – NYT / Suicide Risk Not New – Globe / Prozac no different Tue, 21 Sep 2004 The FDA failed to stop drug manufacturers from flooding the air waves and the scientific literature with false and scientifically invalid claims-based on partial data. “The FDA…
